Nephrocare Health Services to Discuss FY26 Results on May 20 Earnings Call

Consolidated Revenue stood at ₹263.05 Cr in Q3 FY26, with Net Profit at ₹32.24 Cr.

Announcement

Nephrocare Health Services Ltd., operating as Nephroplus, has announced its Q4 FY26 earnings conference call. The meeting is scheduled for Wednesday, May 20, 2026, at 4:00 PM IST. During the call, the company will present its audited standalone and consolidated financial results for the fiscal year ending March 31, 2026. Discussions will be limited to publicly available information. Shareholders and analysts will receive access to the company's complete audited financial performance for FY26.

Investor Focus

This call is a significant event for investors to evaluate Nephroplus's full-year financial performance. It will offer insights into the company's revenue growth, profitability, and operational efficiency across its domestic and international segments for FY26. Management commentary will be key to understanding the company's strategic direction, expansion plans, and outlook for the upcoming fiscal year. Investors will also have the opportunity to seek clarifications directly from management.

Company Background

Nephrocare Health Services Ltd. recently completed its Initial Public Offering (IPO) and listed on the BSE and NSE on December 17, 2025. The company has demonstrated strong growth, with FY25 revenues reaching ₹7,558 million (up 33.5% year-over-year) and net profit at ₹671 million (up 91.0% year-over-year). International business has been a major contributor to this growth, accounting for 41% of total revenue in the first nine months of FY26, an increase from 12% in FY23. The company operates a large network of dialysis clinics, with a strong presence in tier II and tier III cities in India.

Legal Matter

The company has disclosed that it filed a Writ Petition on April 02, 2026, before the High Court of Jammu & Kashmir and Ladakh at Srinagar. This filing relates to a dispute involving claims of approximately ₹28.99 crore. These claims are for operational dues, termination penalties, and damages stemming from a Master Medical Services Agreement with Nayati Healthcare and Research Private Limited. Nephrocare Health Services maintains that these claims do not qualify as 'operational debt'.

Competitive Landscape

Nephroplus operates in a competitive healthcare services sector. Key peers in the Indian dialysis market include Apollo Dialysis Clinics and DCDC Kidney Care, both recognized for their extensive clinic networks and service offerings. The Renal Project is another competitor, focusing on home dialysis services.